What is Angelman Syndrome?

Angelman syndrome is a genetic disorder resulting in severe intellectual disability. It affects one in 12,000 to 20,000 children, and accounts for 6% of severely mentally disabled children who also have epilepsy.

Symptoms and signs

Children with this condition often show developmental delay which becomes apparent by 6-12 months, and progress to be eventually classified with severe developmental delay. Symptoms include; ataxia with trembling limbs, impaired expressive speech and a typically happy hyperactive temperament, with a short attention span, laughing, and sleep disturbances.

It was once known as “happy puppet syndrome”. It is notable that the characteristic features of the syndrome are usually apparent only after the age of one year. Less universal findings of Angelman syndrome include:

  • microcephaly
  • flat neck
  • pale skin and fair hair
  • widely spaced teeth
  • tongue protrusion and open mouth
  • scoliosis
  • constipation
  • feeding difficulties.

Genetic basis of Angelman syndrome

The disease is the result of a missing UBE3A gene on chromosome 15q. In over 70% of patients it is due to maternal deletions of 15q11-13, which also produces the most severe form of the syndrome. Other forms of the syndrome are due to uniparental disomy, imprinting center mutations and UBE3A mutations. This gene is part of a cluster of genes coding for GABA-receptor subunits. About 20% show no detectable mutation.

Diagnosis and treatment

Diagnosis is based on the typical physical and developmental features, EEG changes, especially large-amplitude slow-spike waves, and genetic testing. DNA methylation testing detects the condition in about 80% of patients.

Treatment involves seizure control with anticonvulsants like sodium valproate, benzodiazepines and ethosuximide. Other components of therapy include physiotherapy, speech therapy and special education, which are required to improve the patient’s physical and mental skills, and prevent scoliosis and immobility.

Genetic counseling is necessary to assess the risk to siblings or other members of the extended family. The risk of the condition is more than 50% when the mechanism is via UBE3A mutations, but much less with other mechanisms of chromosomal loss.


Further Reading

Last Updated: Aug 23, 2018

Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2018, August 23). What is Angelman Syndrome?. News-Medical. Retrieved on January 25, 2021 from https://www.news-medical.net/health/What-is-Angelman-Syndrome.aspx.

  • MLA

    Thomas, Liji. "What is Angelman Syndrome?". News-Medical. 25 January 2021. <https://www.news-medical.net/health/What-is-Angelman-Syndrome.aspx>.

  • Chicago

    Thomas, Liji. "What is Angelman Syndrome?". News-Medical. https://www.news-medical.net/health/What-is-Angelman-Syndrome.aspx. (accessed January 25, 2021).

  • Harvard

    Thomas, Liji. 2018. What is Angelman Syndrome?. News-Medical, viewed 25 January 2021, https://www.news-medical.net/health/What-is-Angelman-Syndrome.aspx.


  1. Lynda Dayam Torres P Lynda Dayam Torres P Colombia says:

    Excelente información.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.